Stay updated on NSCLC Combination Therapy Clinical Trial
Sign up to get notified when there's something new on the NSCLC Combination Therapy Clinical Trial page.

Latest updates to the NSCLC Combination Therapy Clinical Trial page
- Check4 days agoChange DetectedExpanded contact numbers and extended time range (up to ~38 months) replacing older values (up to ~34 months) and older phone number formats with new ones.SummaryDifference0.6%
- Check12 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference1%
- Check19 days agoChange DetectedNo substantive content changes detected; page version updated from v3.0.2 to v3.1.0, with a large list of added contact numbers but no core content or pricing/availability changes.SummaryDifference0.0%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedNew site identity and address added, contact options expanded, status updated to Active/not Recruiting, and revision advanced to v3.0.2, replacing the previous v3.0.1 and removing the old Vilniaus Miestas data.SummaryDifference1%
- Check40 days agoChange DetectedThe page has been updated to reflect that the study now has 179 locations and is actively recruiting, with new contact information provided for the Study Coordinator in Oceanside, California.SummaryDifference0.9%
- Check47 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility locations across various countries, as well as the reintroduction of the drug Sacituzumab Govitecan. Several previously listed locations and related topics have been removed.SummaryDifference21%
Stay in the know with updates to NSCLC Combination Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Combination Therapy Clinical Trial page.